89bio, Inc. (ETNB) Financials

Stock symbol ETNB is outdated, potentially delisted? Maybe it is available on other exchange?

ETNB Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2024	458.3 million	80.2 million
June 30, 2024	582.1 million	67.2 million
March 31, 2024	577.3 million	66.8 million
Dec. 31, 2023	596.3 million	60.0 million

ETNB Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2024	-145.4 million	5.3 million
June 30, 2024	-61.2 million	5.2 million
March 31, 2024	-39.7 million	5.0 million
Dec. 31, 2023	-34.3 million	4.0 million

ETNB Net Income

No data available :(

ETNB Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2024	423.8 million	1.3 million	-
June 30, 2024	531.4 million	21.8 million	2.2 million
March 31, 2024	562.3 million	24.7 million	2.3 million
Dec. 31, 2023	578.9 million	26.6 million	2.3 million

ETNB Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2024	10.7 million
June 30, 2024	99.8 million
March 31, 2024	95.8 million
Dec. 31, 2023	80.7 million

ETNB Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2024	-	141.4 million	10.5 million	-
June 30, 2024	-	44.9 million	8.6 million	-12000
March 31, 2024	-	47.4 million	9.8 million	-9000
Dec. 31, 2023	4000	33.6 million	7.6 million	-16000

ETNB Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2024	-	-
June 30, 2024	-	12000
March 31, 2024	-	9000
Dec. 31, 2023	234000	16000

ETNB

Price: $14.84

52 week price:

4.16

15.06

Payout Ratio Range:

-0.21%

-0.00%

Earnings Per Share: -3.69 USD

P/E Ratio: -4.02

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.6 million

Market Capitalization: 2.2 billion

Links:

ETNB on Yahoo Finance